Jason Bouvier
Stock Analyst at Scotiabank
(2.08)
# 2,825
Out of 4,734 analysts
9
Total ratings
50%
Success rate
6.94%
Average return
Main Sectors:
Stocks Rated by Jason Bouvier
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
OVV Ovintiv | Maintains: Sector Outperform | $50 → $53 | $45.74 | +15.87% | 3 | Nov 18, 2024 | |
IMO Imperial Oil | Downgrades: Sector Perform | $110 | $68.42 | +60.77% | 2 | Sep 25, 2024 | |
SU Suncor Energy | Maintains: Sector Perform | $61 → $60 | $39.03 | +53.73% | 1 | Jul 12, 2024 | |
CVE Cenovus Energy | Maintains: Sector Outperform | $35 → $34 | $15.06 | +125.76% | 1 | Jul 12, 2024 | |
CNQ Canadian Natural Resources | Maintains: Sector Perform | $114 → $57 | $31.12 | +83.16% | 1 | Jun 11, 2024 | |
IKNA Ikena Oncology | Initiates: Buy | n/a | $1.50 | - | 1 | Apr 20, 2021 |
Ovintiv
Nov 18, 2024
Maintains: Sector Outperform
Price Target: $50 → $53
Current: $45.74
Upside: +15.87%
Imperial Oil
Sep 25, 2024
Downgrades: Sector Perform
Price Target: $110
Current: $68.42
Upside: +60.77%
Suncor Energy
Jul 12, 2024
Maintains: Sector Perform
Price Target: $61 → $60
Current: $39.03
Upside: +53.73%
Cenovus Energy
Jul 12, 2024
Maintains: Sector Outperform
Price Target: $35 → $34
Current: $15.06
Upside: +125.76%
Canadian Natural Resources
Jun 11, 2024
Maintains: Sector Perform
Price Target: $114 → $57
Current: $31.12
Upside: +83.16%
Ikena Oncology
Apr 20, 2021
Initiates: Buy
Price Target: n/a
Current: $1.50
Upside: -